ReviewJournal of nutrition and metabolism2026
Thiamine Use in Hospitalized Patients: A Clinical Review.
Review in Journal of nutrition and metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Association of thiamine supplementation with 30-day mortality among ICU patients with sepsis-associated delirium.Scientific reports · 2026Article
- Thiamine Use in Hospitalized Patients: A Clinical Review.Journal of nutrition and metabolism · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thiamine, or vitamin B1, is a water-soluble vitamin necessary for multiple metabolic processes throughout the human body. Thiamine is primarily obtained from our diet and is found in sources such as whole grains, legumes, and pork. Short bowel syndrome, severe malnutrition, alcohol use disorder, or diuretic use can all lead to thiamine deficiency. Thiamine deficiency may contribute to significant morbidity if not promptly identified and treated. Thiamine supplementation has been established as the primary treatment for patients with Wernicke's encephalopathy. Supplementation of thiamine is also commonly provided to patients at risk for refeeding syndrome to prevent exacerbation of an underlying thiamine deficiency when nutrition is reintroduced. More recent studies have investigated thiamine supplementation for a broader use in patients with sepsis, impaired lactate clearance, and delirium. The purpose of this review is to provide an overview of the indications for thiamine supplementation in hospitalized patients, analyze literature for historical and emerging thiamine supplementation utilization, and provide a framework for supplementation based on indication.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.